ホーム カタログ 品質とCOA 概要 お問い合わせ カート
カタログを閲覧
$59以上で送料無料 · 米国 $7.99(48時間)・世界 $14.99(5日) · 目立たない梱包 · 暗号通貨対応
凍結乾燥 · 5 mg + 5 mg / vial CJC-1295 No DAC + Ipamorelin Blend 5 mg + 5 mg / vial — HPLC検証済みペプチドバイアル
Growth & Anabolic 5 mg + 5 mg / vial

CJC-1295 + Ipamorelin Blend (5mg + 5mg)

GHRH + selective GHRP synergistic stack · Co-lyophilized · Single vial, one injection

Premium Grade ベストセラー

Co-lyophilized GHRH + selective GHRP stack — the reference combination for synergistic pulsatile GH release.

CAS番号
Blend
分子量
Mixed (3 368 + 712 Da)
純度
≥ 99.0% (HPLC, each component)
保存
−20 °C、凍結乾燥
アミノ酸配列 CJC-1295 (Mod GRF 1-29) co-lyophilized with Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
バンドルを選択
本日お支払い $102 3バイアル・1本 $34
$59以上で無料米国向け $7.99(48時間)・世界向け $14.99(5営業日)
目立たない梱包目立たない断熱梱包、外部に化合物名なし。

分析証明書

ロット別分析報告書 — HPLC、ESI-MS、LALエンドトキシン、重金属、滅菌性

現在のロットCJC772
リリース済み2026-04-17
HPLC純度99.77%
エンドトキシン(LAL)合格 · < 0.5 EU/mg

CJC-1295 No DAC + Ipamorelin Blendについて

Buy the CJC-1295 + Ipamorelin blend at IGF1 Shop. This pre-blended vial contains 5mg of CJC-1295 (No DAC, also called Modified GRF 1-29) co-lyophilized with 5mg of Ipamorelin in a single vial — the reference GHRH + GHRP combination for synergistic pulsatile growth hormone release. CJC-1295 No DAC primes the pituitary via the GHRH receptor; Ipamorelin selectively triggers the release via the ghrelin receptor (GHS-R1a). The two combined produce a GH pulse two to five times larger than either alone, without raising cortisol or prolactin. Each blend lot is HPLC ≥99% for each component, mass-spec verified, with a per-lot COA.

別名: CJC-1295 Ipamorelin · CJC + Ipamorelin blend · GHRH/GHRP stack · Mod GRF + Ipamorelin

CJC-1295 No DAC + Ipamorelin Blend — 作用機序と仕様

This blend co-lyophilizes the foundational GHRH analog (Mod GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin in a single vial. The two compounds activate distinct receptors on somatotrophs and produce a synergistic GH pulse far greater than either compound alone, without elevating cortisol or prolactin.

品質とリリース基準

CJC-1295 No DAC + Ipamorelin Blendのすべてのロットは、逆相HPLC(参照標準に対して220 nmで面積純度≥ 99%)、分子量のESI質量分析確認、および0.5 EU/mg未満のLimulus Amebocyte Lysate(LAL)エンドトキシン試験に合格した後にのみリリースされます。ロット固有の分析証明書は注文に同梱され、購入前にリクエストに応じて提供可能です。

よくある質問

CJC-1295 No DAC + Ipamorelin Blend — よくあるご質問

Why blend CJC-1295 (No DAC) with Ipamorelin?
CJC-1295 No DAC is a GHRH analog — it primes the pituitary to release GH. Ipamorelin is a selective GHRP — it triggers the actual release through the ghrelin receptor pathway. Combined, the two produce a GH pulse that is synergistic, two to five times larger than either compound alone, without raising cortisol or prolactin.
What is the standard blend protocol?
The most common protocol is 100 mcg of each peptide together, one to three times per day, subcutaneously. Many users dose once first thing in the morning (fasted) and once 30 minutes before bed. With a 5mg + 5mg blend vial reconstituted in 2mL bacteriostatic water, 0.04mL (4 units on a U-100) delivers 100mcg of each.
How long until effects are noticeable?
Sleep quality typically improves within the first week of the CJC-1295 + Ipamorelin blend. Recovery, skin quality, and body-composition changes generally appear after 4-8 weeks of consistent dosing. Most users run blocks of 8-12 weeks followed by a 4-week break to prevent receptor desensitization.
How should the vial be reconstituted and stored?
Add 2mL of bacteriostatic water down the side of the vial, swirl until clear, do not shake. Keep refrigerated at 2-8 °C and use within 30 days of reconstitution. Pre-reconstitution shelf life of the lyophilized blend is two years at -20 °C.
What purity testing does the blend carry?
Each peptide in the CJC-1295 + Ipamorelin blend is independently HPLC ≥99%, then co-lyophilized in a 1:1 mass ratio in the same vial. Identity is confirmed by ESI mass-spec, endotoxin by LAL <0.5 EU/mg, sterility per USP <71>. The COA is issued by an ISO 17025 laboratory and tied to your lot.
Can I run the blend with other peptides like BPC-157 or TB-500?
Yes — the CJC-1295 + Ipamorelin blend is commonly stacked with healing peptides like BPC-157 or TB-500, taken in separate syringes at different times of day. Avoid stacking with other GHRP/GHRH peptides simultaneously, as it provides no added benefit and accelerates receptor desensitization.